In future studies, it will be important to further characterize the life history of bmx hearts, identify preclinical changes, discover useful biomarkers for preclinical drug testing and determine the impact of various stressors on bmx cardiomyopathy. The gene discussed is BMX; the disease is cardiomyopathy.